In the study of Ying et al. [34], they suggested that BMP7 may antagonize transforming growth factor β1 (TGFβ1) in tumorigenesis-associated epithelial-mesenchymal transition (EMT) in breast cancer, so BMP7 may be a promising therapeutic target for treating breast cancer. The gene discussed is TGFB1; the disease is breast carcinoma.